Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.

Davido DJ, Tu EM, Wang H, Korom M, Gazquez Casals A, Reddy PJ, Mostafa HH, Combs B, Haenchen SD, Morrison LA.

J Virol. 2018 Aug 16;92(17). pii: e01036-18. doi: 10.1128/JVI.01036-18. Print 2018 Sep 1.

2.

Herpes Simplex Virus 1 Mutant with Point Mutations in UL39 Is Impaired for Acute Viral Replication in Mice, Establishment of Latency, and Explant-Induced Reactivation.

Mostafa HH, Thompson TW, Konen AJ, Haenchen SD, Hilliard JG, Macdonald SJ, Morrison LA, Davido DJ.

J Virol. 2018 Mar 14;92(7). pii: e01654-17. doi: 10.1128/JVI.01654-17. Print 2018 Apr 1.

3.

Development of a novel cell-based assay to monitor the transactivation activity of the HSV-1 protein ICP0.

Fowler AM, Shinogle HE, Davido DJ.

Antiviral Res. 2015 Aug;120:1-6. doi: 10.1016/j.antiviral.2015.04.012. Epub 2015 Apr 30.

4.

A quantitative assay to monitor HSV-1 ICP0 ubiquitin ligase activity in vitro.

Boutell C, Davido DJ.

Methods. 2015 Nov 15;90:3-7. doi: 10.1016/j.ymeth.2015.04.004. Epub 2015 Apr 8.

5.

Herpes simplex virus 1 upregulates p35, alters CDK-5 localization, and stimulates CDK-5 kinase activity during acute infection in neurons.

Mostafa HH, van Loben Sels JM, Davido DJ.

J Virol. 2015 May;89(9):5171-5. doi: 10.1128/JVI.00106-15. Epub 2015 Feb 18.

6.

A Phospho-SIM in the Antiviral Protein PML is Required for Its Recruitment to HSV-1 Genomes.

Smith MC, Box AC, Haug JS, Lane WS, Davido DJ.

Cells. 2014 Dec 10;3(4):1131-58. doi: 10.3390/cells3041131.

7.

HSV-1 ICP0: An E3 Ubiquitin Ligase That Counteracts Host Intrinsic and Innate Immunity.

Lanfranca MP, Mostafa HH, Davido DJ.

Cells. 2014 May 20;3(2):438-54. doi: 10.3390/cells3020438.

8.

Herpes simplex virus 1 ICP22 but not US 1.5 is required for efficient acute replication in mice and VICE domain formation.

Mostafa HH, Davido DJ.

J Virol. 2013 Dec;87(24):13510-9. doi: 10.1128/JVI.02424-13. Epub 2013 Oct 2.

9.
10.

hTERT extends the life of human fibroblasts without compromising type I interferon signaling.

Smith MC, Goddard ET, Perusina Lanfranca M, Davido DJ.

PLoS One. 2013;8(3):e58233. doi: 10.1371/journal.pone.0058233. Epub 2013 Mar 5.

11.

HSV-1 ICP22: hijacking host nuclear functions to enhance viral infection.

Rice SA, Davido DJ.

Future Microbiol. 2013 Mar;8(3):311-21. doi: 10.2217/fmb.13.4. Review.

PMID:
23464370
12.

HSV-1 strain McKrae is more neuroinvasive than HSV-1 KOS after corneal or vaginal inoculation in mice.

Wang H, Davido DJ, Morrison LA.

Virus Res. 2013 May;173(2):436-40. doi: 10.1016/j.virusres.2013.01.001. Epub 2013 Jan 20.

13.

N-terminal phosphorylation sites of herpes simplex virus 1 ICP0 differentially regulate its activities and enhance viral replication.

Mostafa HH, Thompson TW, Davido DJ.

J Virol. 2013 Feb;87(4):2109-19. doi: 10.1128/JVI.02588-12. Epub 2012 Dec 5.

14.

Genome sequence of herpes simplex virus 1 strain McKrae.

Macdonald SJ, Mostafa HH, Morrison LA, Davido DJ.

J Virol. 2012 Sep;86(17):9540-1. doi: 10.1128/JVI.01469-12.

15.

Genome sequence of herpes simplex virus 1 strain KOS.

Macdonald SJ, Mostafa HH, Morrison LA, Davido DJ.

J Virol. 2012 Jun;86(11):6371-2. doi: 10.1128/JVI.00646-12.

16.

Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation.

Mostafa HH, Thompson TW, Kushnir AS, Haenchen SD, Bayless AM, Hilliard JG, Link MA, Pitcher LA, Loveday E, Schaffer PA, Davido DJ.

J Virol. 2011 Dec;85(23):12631-7. doi: 10.1128/JVI.05661-11. Epub 2011 Sep 21.

17.

HSV-1 ICP0: paving the way for viral replication.

Smith MC, Boutell C, Davido DJ.

Future Virol. 2011 Apr;6(4):421-429.

18.

CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β.

Smith MC, Bayless AM, Goddard ET, Davido DJ.

Antiviral Res. 2011 Sep;91(3):259-66. doi: 10.1016/j.antiviral.2011.06.009. Epub 2011 Jun 22.

19.

Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replication in vivo.

Haenchen SD, Utter JA, Bayless AM, Dobrowsky RT, Davido DJ.

J Neurovirol. 2010 Oct;16(5):405-9. doi: 10.3109/13550284.2010.513030.

20.

Role of nuclear factor Y in stress-induced activation of the herpes simplex virus type 1 ICP0 promoter.

Kushnir AS, Davido DJ, Schaffer PA.

J Virol. 2010 Jan;84(1):188-200. doi: 10.1128/JVI.01377-09.

21.

Transient expression of herpes simplex virus type 1 ICP22 represses viral promoter activity and complements the replication of an ICP22 null virus.

Bowman JJ, Orlando JS, Davido DJ, Kushnir AS, Schaffer PA.

J Virol. 2009 Sep;83(17):8733-43. doi: 10.1128/JVI.00810-09. Epub 2009 Jun 17.

22.

A flow cytometric assay for the study of E3 ubiquitin ligase activity.

Hilliard JG, Cooper AL, Slusser JG, Davido DJ.

Cytometry A. 2009 Jul;75(7):634-41. doi: 10.1002/cyto.a.20738.

23.

Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function.

Davido DJ, von Zagorski WF, Lane WS, Schaffer PA.

J Virol. 2005 Jan;79(2):1232-43.

24.
26.

Butyrate and propionate downregulate ERK phosphorylation in HT-29 colon carcinoma cells prior to differentiation.

Davido DJ, Richter F, Boxberger F, Stahl A, Menzel T, Lührs H, Löffler S, Dusel G, Rapp UR, Scheppach W.

Eur J Cancer Prev. 2001 Aug;10(4):313-21.

PMID:
11535873
28.
29.
30.

Supplemental Content

Loading ...
Support Center